Sarah Demko
Psychiatric/Mental Health · Cleveland, OHNPI 1356866990
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (32.7%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. SK Life Science, Inc. accounts for 72.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $14,918 and has fallen 95.6% since, to $649 in 2025. Among psychiatric/mental health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $260.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SK Life Science, Inc.$20K
- Livanova USA, Inc.$3K
- Eisai Inc.$2K
- Neurelis, Inc.$811
- Biohaven Pharmaceuticals, Inc.$530
- Biohaven Pharmaceutical Holding Company Ltd.$158
- plus $716 from 6 others
What the payments were for
- Consulting fees$4,13315%
- Speaking & faculty fees$4,80017%
- Grants$9,00033%
- Travel & lodging$4,63117%
- Food & beverage$4,94718%
- Education$510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SK Life Science, Inc. | 35 | $20,086 |
| Livanova USA, Inc. | 23 | $2,806 |
| Eisai Inc. | 11 | $2,455 |
| Neurelis, Inc. | 5 | $811 |
| Biohaven Pharmaceuticals, Inc. | 16 | $530 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $158 |
| Jazz Pharmaceuticals Inc. | 2 | $144 |
| AbbVie | 2 | $137 |
| Neurocrine Biosciences, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $123 |
| E.r. Squibb & Sons, L.L.C. | 1 | $123 |
| UCB, Inc. | 2 | $64 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XCOPRI$18,924
- Fycompa$2,224
- VNS - Sentiva$1,383
- VNS Therapy$965
- VALTOCO$723
- NURTEC ODT$461
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$237
- Epidiolex$125
- INGREZZA$125
- VRAYLAR$125
- Auvelity$123
- COBENFY$123
How this compares
$27,561 in reported general payments places this provider in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium | 22 | $3,243 |
| Levetiracetam | 56 | $1,987 |
| Levetiracetam ErLevetiracetam | 14 | $1,367 |
| Phenytoin Sodium Extended | 17 | $441 |
| Fluoxetine Hcl | 11 | $180 |
| Risperidone | 17 | $146 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Cleveland
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
- Rachael McLaughlinMaple Heights$114K
- Danielle MorroneCanfield$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.